Excipients

Product Search

INN
Manufacturer
Application

News

23.07.2012
Change of Specification for Kollivax S and Kolliwax S Fine >>>
03.12.2011
Kollidon 25 - re-test period has been extended >>>
16.11.2011
Rebranding of BASF & COGNIS products >>>

PROSOLV«ODT


JRS PHARMA proudly introduces its newest product derived from the PROSOLV® Technology Platform, PROSOLV® ODT. This innovative orally disintegrating tablet matrix technology is the unique combination of soluble and insoluble ingredients manufactured using JRS PHARMA's co-processing technology.

PROSOLV® ODT addresses formulation and manufacturing challenges with robust functional performance required for high speed tablet manufacture. Patients experience a tablet with pleasing mouth feel and fast disintegration in the oral cavity without needing water. With no licensing and royalty agreements required, JRS PHARMA makes PROSOLV® ODT ready to use for scientists, manufacturing, and business professionals alike.

PROSOLV® ODT is an orally disintegrating tablet excipient matrix. It allows a rapid formulation development and quality tablet manufacture.


Grade  Ingredients Average Particle
Size by Laser
Diffraction (µm)
Bulk Density
(g/cm³)
Main Application
PROSOLV® ODT

Microcrystalline Cellulose

Colloidal Silicon  Dioxide

Mannitol

Fructose

Crospovidone

100 0,45 - 0,65

 PROSOLV® ODT is simple-to-use co-processed composite derived from JRS PHARMA's patented PROSOLV® Technology. Its primary application is for the development and manufacture of orally disintegrating tablets allowing the discrete and convenient administering of medicines without water for high patient compliance.